View in EDS

Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells.

Saved in:
Bibliographic Details
Title: Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells.
Authors: Jeong JH; Curocell Inc., Daejeon 34002, Republic of Korea., Seo YR; Curocell Inc., Daejeon 34002, Republic of Korea., Yu SR; Curocell Inc., Daejeon 34002, Republic of Korea., Lee HB; Curocell Inc., Daejeon 34002, Republic of Korea., Lee HJ; Curocell Inc., Daejeon 34002, Republic of Korea., Cho HJ; Curocell Inc., Daejeon 34002, Republic of Korea., Kim HC; Curocell Inc., Daejeon 34002, Republic of Korea., Lee YH; Curocell Inc., Daejeon 34002, Republic of Korea.
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2026 Feb 18; Vol. 34 (1), pp. 201158. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41809371
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jeong+JH%22">Jeong JH</searchLink>; Curocell Inc., Daejeon 34002, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Seo+YR%22">Seo YR</searchLink>; Curocell Inc., Daejeon 34002, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yu+SR%22">Yu SR</searchLink>; Curocell Inc., Daejeon 34002, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+HB%22">Lee HB</searchLink>; Curocell Inc., Daejeon 34002, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+HJ%22">Lee HJ</searchLink>; Curocell Inc., Daejeon 34002, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cho+HJ%22">Cho HJ</searchLink>; Curocell Inc., Daejeon 34002, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HC%22">Kim HC</searchLink>; Curocell Inc., Daejeon 34002, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+YH%22">Lee YH</searchLink>; Curocell Inc., Daejeon 34002, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2026 Feb 18; Vol. 34 (1), pp. 201158. <i>Date of Electronic Publication: </i>2026 Feb 18 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41809371
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omton.2026.201158
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 201158
    Titles:
      – TitleFull: Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jeong JH
      – PersonEntity:
          Name:
            NameFull: Seo YR
      – PersonEntity:
          Name:
            NameFull: Yu SR
      – PersonEntity:
          Name:
            NameFull: Lee HB
      – PersonEntity:
          Name:
            NameFull: Lee HJ
      – PersonEntity:
          Name:
            NameFull: Cho HJ
      – PersonEntity:
          Name:
            NameFull: Kim HC
      – PersonEntity:
          Name:
            NameFull: Lee YH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 02
              Text: 2026 Feb 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2950-3299
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular therapy. Oncology
              Type: main
ResultId 1